Trial Profile
Proof-of-concept study of CT 327 in patients with inflammatory pain
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 16 Dec 2010
Price :
$35
*
At a glance
- Drugs Pegcantratinib (Primary)
- Indications Inflammatory pain
- Focus Therapeutic Use
- Sponsors Creabilis Therapeutics
- 16 Dec 2010 New trial record